Zhaoke Ophthalmology Limited (6622.HK)
- Previous Close
1.660 - Open
1.660 - Bid 1.630 x --
- Ask 1.640 x --
- Day's Range
1.610 - 1.660 - 52 Week Range
1.210 - 2.230 - Volume
876,500 - Avg. Volume
2,669,851 - Market Cap (intraday)
895.668M - Beta (5Y Monthly) 1.00
- PE Ratio (TTM)
-- - EPS (TTM)
-0.450 - Earnings Date Mar 24, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
2.46
Zhaoke Ophthalmology Limited, an ophthalmic pharmaceutical company, engages in the research, development, manufacture, and commercialization of therapies that address unmet medical needs in the People's Republic of China, South Korea, and Hong Kong. It is developing various drugs that cover ophthalmic indications, including dry eye diseases, wet age-related macular degeneration, diabetic macular edema, myopia, and glaucoma. The company was formerly known as China Ophthalmology Focus Limited. Zhaoke Ophthalmology Limited was incorporated in 2017 and is headquartered in Guangzhou, the People's Republic of China.
www.zkoph.comRecent News: 6622.HK
View MorePerformance Overview: 6622.HK
Trailing total returns as of 5/8/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 6622.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 6622.HK
View MoreValuation Measures
Market Cap
906.59M
Enterprise Value
-108.59M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
12.27
Price/Book (mrq)
0.45
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-8.02%
Return on Equity (ttm)
-12.03%
Revenue (ttm)
69.32M
Net Income Avi to Common (ttm)
-237.49M
Diluted EPS (ttm)
-0.450
Balance Sheet and Cash Flow
Total Cash (mrq)
1.19B
Total Debt/Equity (mrq)
12.56%
Levered Free Cash Flow (ttm)
-295.31M